Zenas BioPharma (ZBIO) announced the appointment of Lisa von Moltke, M.D., as its Head of Research and Development, R&D, and Chief Medical Officer, CMO. Dr. von Moltke brings over 30 years of U.S. and international drug development experience spanning multiple therapeutic areas, including autoimmune diseases, early- and late-stage clinical development, and commercialization at both large and smaller emerging growth companies.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBIO:
Questions or Comments about the article? Write to editor@tipranks.com